“…A range of theoretical approaches to facilitate implementation of disinvestment decisions has been proposed but the authors do not report application or evaluation of these strategies in the disinvestment context. These include communication and educational materials [6, 7, 63, 70, 107, 109]; financial incentives and pay-for-performance [46, 70, 109, 126, 127]; reinvestment of resources saved [8, 18, 107, 128]; clinical champions [18, 77]; clinical pharmacists to monitor and advise prescribers [129]; quality standards [70, 127]; professional standards, maintenance-of-certification activities and practice audit [70]; prompts through guidelines, protocols, clinical pathways and decision support systems [6, 7, 24, 48, 109, 126, 127]; requirements to report variations from mandatory guidelines [127]; monitoring and reporting of outcomes [107, 109, 126]; public reporting of provider performance [70, 109, 126, 127]; training and re-organisation of staffing and equipment [107]; and “ picking low hanging fruit ” before tackling more difficult projects [18]. The Schmidt framework for disinvestment notes that both process and outcome evaluations should be undertaken but provides no other details [95].…”